ERYTHROMYCIN INHIBITION OF LIPOPOLYSACCHARIDE-STIMULATED TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION BY HUMAN MONOCYTES INVITRO

被引:61
作者
IINO, Y
TORIYAMA, M
NATORI, Y
KUDO, K
YUO, A
机构
[1] NATL MED CTR, INST CLIN RES, TOKYO, JAPAN
[2] NATL MED CTR, DEPT OTOLARYNGOL, TOKYO, JAPAN
[3] NATL MED CTR, DEPT RESP DIS, TOKYO, JAPAN
关键词
ERYTHROMYCIN; LIPOPOLYSACCHARIDE; MONOCYTES; SINOBRONCHIAL SYNDROME; TUMOR-NECROSIS-FACTOR-ALPHA;
D O I
10.1177/0003489492101S1005
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
The mechanism of clinical effectiveness of low-dose and long-term erythromycin (EM) treatment for diffuse panbronchiolitis, sinobronchial syndrome, and associated otitis media with effusion was investigated by studying the effects of EM on tumor necrosis factor alpha (TNF-alpha) production by cultured human monocytes stimulated with lipopolysaccharide. At concentrations of 0.1 mug/mL or more, EM inhibited TNF-alpha release from human monocytes stimulated by lipopolysaccharide in a dose-dependent manner. Of the other macrolides tested, roxithromycin, an EM derivative, also showed significant inhibition of TNF-alpha production, where as josamycin failed to inhibit TNF-alpha release from monocytes. Nonmacrolidic drugs such as minocycline hydrochloride, ofloxacin, or penicillin G had no significant effect on TNF-alpha production. These results suggest that the clinical improvement of chronic respiratory diseases by EM may depend on the suppression of production of inflammatory cytokines such as TNF-alpha.
引用
收藏
页码:16 / 20
页数:5
相关论文
共 23 条
[1]   EFFECTS OF 2 ERYTHROMYCINS, DOXYCYCLINE AND PHENOXYMETHYLPENICILLIN ON HUMAN-LEUKOCYTE CHEMOTAXIS INVITRO [J].
AHO, P ;
MANNISTO, PT .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 21 :29-32
[3]   STUDIES ON THE EFFECTS OF INGESTION OF A SINGLE 500 MG ORAL DOSE OF ERYTHROMYCIN STEARATE ON LEUKOCYTE MOTILITY AND TRANSFORMATION AND ON RELEASE INVITRO OF PROSTAGLANDIN-E2 BY STIMULATED LEUKOCYTES [J].
ANDERSON, R ;
FERNANDES, AC ;
EFTYCHIS, HE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 14 (01) :41-50
[4]   CELLULAR UPTAKE AND SUBCELLULAR-DISTRIBUTION OF ROXITHROMYCIN AND ERYTHROMYCIN IN PHAGOCYTIC-CELLS [J].
CARLIER, MB ;
ZENEBERGH, A ;
TULKENS, PM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1987, 20 :47-56
[5]   EVALUATION OF THE IMMUNOSTIMULATING ACTIVITY OF ERYTHROMYCIN IN MAN [J].
FRASCHINI, F ;
SCAGLIONE, F ;
FERRARA, F ;
MARELLI, O ;
BRAGA, PC ;
TEODORI, F .
CHEMOTHERAPY, 1986, 32 (03) :286-290
[6]  
IINO Y, 1985, ACTA OTO-LARYNGOL, V100, P45
[7]  
IINO Y, 1991, NIPPON JIBIINKOKA GA, V94, P1537
[8]  
JOHNSON JD, 1980, J LAB CLIN MED, V95, P429
[9]  
KIKUCHI S, 1991, Practica Otologica Kyoto, V84, P41
[10]   ENHANCED INTERLEUKIN PRODUCTION AFTER LONG-TERM ADMINISTRATION OF ERYTHROMYCIN STEARATE [J].
KITA, E ;
SAWAKI, M ;
NISHIKAWA, F ;
MIKASA, K ;
YAGYU, Y ;
TAKEUCHI, S ;
YASUI, K ;
NARITA, N ;
KASHIBA, S .
PHARMACOLOGY, 1990, 41 (04) :177-183